Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Nature medicine
- Publicado em
- 7 jan 2025
- Citações
- 21
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial
Pablo Garcia-Manau, Erika Bonacina, Raquel Martin-Alonso, Lourdes Martín, Ana Palacios, Maria Luisa Sanchez-Camps, Cristina Lesmes, Ivan Hurtado, Esther Perez, Albert Tubau et al.
Descritores MeSH
- Placenta Growth Factor
- Fetal Growth Retardation
- Ultrasonography, Prenatal
- Ultrasonography, Doppler
- Vascular Endothelial Growth Factor Receptor-1
- Angiogenesis Inducing Agents
- Infant, Newborn
- Infant, Small for Gestational Age
- Pregnancy
- Adult
Veja também
Estudos relacionados
- Placental lesions in small for gestational age fetuses with and without clinical features of fetal growth restriction: a secondary analysis of the Doppler Ratio In fetal Growth restriction Intervention Trial At (near) Term (DRIGITAT) study
- Diagnostic performance of 32 vs 36 weeks ultrasound in predicting late-onset fetal growth restriction and small-for-gestational-age neonates: a systematic review and meta-analysis
- A systematic review and critical evaluation of quality of clinical practice guidelines on fetal growth restriction
- Severe smallness as predictor of adverse perinatal outcome in suspected late small-for-gestational-age fetuses: systematic review and meta-analysis